Clinical Trial Update: Long Term Study of Solifenacin Succinate and Tamsulosin Hydrochloride Oral Controlled Absorption System (OCAS) in Males With Lower Urinary Tract Symptoms [Phase 3]

View source ↗

Summary

Phase 3 long-term trial evaluating the combination of solifenacin succinate and tamsulosin OCAS in men with lower urinary tract symptoms due to benign prostatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Benign Prostatic Hyperplasia
• Lower Urinary Tract Symptoms

Drugs mentioned

• Flomax (tamsulosin hydrochloride)
• Vesicare (solifenacin succinate)

Snippet

Sponsor: Astellas Pharma Europe B.V. | Conditions: Lower Urinary Tract Symptoms, Benign Prostatic Hyperplasia | Phase 3 | Status: COMPLETED | Results posted: 2016-01-22